Clinical trial
Association of PICP Serum Marker in Patients With LVSD
NCT00232388 · Texas Tech University Health Sciences Center, Other · Terminated
Key facts
| NCT number | NCT00232388 |
|---|---|
| Title | Association of PICP Serum Marker in Patients With LVSD |
| Official title | Phase 1 Study of PICP Serum Marker of Myocardial Fibrosis and Diastolic Function in Patients With Systolic Dysfunction |
| Lead sponsor | Texas Tech University Health Sciences Center, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Systolic Dysfunction |
| Intervention type | Procedure |
| Interventions | Blood draw |
| Enrollment | 45 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Oct 4, 2005 |
| Last update posted | Oct 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: